| Aug 12 |
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
|
| Aug 8 |
AstraZeneca licensing deal boosts Conduit Pharma
|
| Aug 8 |
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
|
| Aug 8 |
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
|
| Jul 16 |
What Happened With Conduit Pharmaceuticals (CDT) Stock Today?
|
| Jul 16 |
Conduit Pharmaceuticals Granted Patent Approval For Autoimmune Diseases Treatment
|
| Jul 16 |
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
|
| Jul 16 |
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
| May 29 |
A Presidio Property Trust Major Investment To Be Part of Russell 2000®
|
